Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Eiger Biopharmaceuticals Inc buy Mori8

Eiger Biopharmaceuticals Inc
Start price
€6.75
02.10.20 / 50%
Target price
-
04.11.21
Performance (%)
0.52%
End price
€6.79
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €6.79. The BUY prediction by Mori8 for Eiger Biopharmaceuticals Inc closed nearly unchanged. Mori8 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Eiger Biopharmaceuticals Inc - - - -
iShares Core DAX® 0.734% 1.458% 17.980% 65.292%
iShares Nasdaq 100 -2.686% -0.146% 3.810% 97.467%
iShares Nikkei 225® -2.261% -2.729% 11.679% 39.755%
iShares S&P 500 -1.346% 0.467% 1.970% 61.093%

Comments by Mori8 for this prediction

In the thread Eiger Biopharmaceuticals Inc diskutieren

Buy Eiger Biopharmaceuticals Inc

Mori8 
0
Report Share
02.10.20 Buy 0.52%


SNY/TBIO Move COVID-19 Vaccine Into Clinic, AVXL's PDD Study Promising, EIGR On Watch


INDIANAPOLIS (dpa-AFX) - Today's Daily Dose brings you news about Eiger BioPharma's COVID-19 ILIAD study results, disappointing results of Servier/Galapagos' knee osteoarthritis drug trial, Anavex Life's Parkinson's disease dementia trial, the progress in Sanofi/Translate Bio's COVID-19 vaccine candidate MRT5500, and Lilly loosening its purse strings to bolster its pipeline with SARM1 programs for axonal degeneration.

Mori8 
0
Report Share
16.10.20 Buy 0.52%
In the thread Trading Eiger Biopharmaceuticals Inc
Prediction Buy
Perf. (%) 0.52%
Target price
Change
Ends at 04.11.21

Die von Mori8 gewählte maximale Laufzeit wurde überschritten

Mori8 
0
Report Share
05.11.21

Stopped prediction by Mori8 for Eiger Biopharmaceuticals Inc

buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€2.50
10.02.23
-
28.02.26
-92.00%
22.08.24

Mori8 
10.02.23 50%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€2.10
07.02.23
-
07.03.23
18.88%
10.02.23

Mori8 
07.02.23 50%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.49
30.01.23
-
28.02.23
23.56%
02.02.23

Mori8 
30.01.23 50%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€0.20
25.02.22
-
-
25.02.22

Mori8 
25.02.22 50%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.16
05.12.21
-
05.12.22
-6.11%
23.12.21

Mori8 
05.12.21 50%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€6.66
16.11.21
-
16.11.22
-22.54%
05.12.21

Mori8 
16.11.21 50%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€9.53
09.10.18
€18.00
12.06.19
-6.82%
12.06.19

Mori8 
14.08.19 50%